Skip to content

Mindfulness and Self-Compassion Intervention for Ostomy Patients Due to Colorectal Cancer on Loneliness (MSC-OP)

The Feasibility of Mindfulness and Self-Compassion Intervention for Loneliness, Stigma and Social Anxiety Among Colorectal Cancer Patients With Ostomy: A Randomized Controlled Pilot Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07809074
Acronym
MSC-OP
Enrollment
20
Registered
2026-09-09
Start date
2026-09-10
Completion date
2027-04-30
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer (CRC), Stoma

Keywords

mindfulness, self-compassion, pilot RCT, loneliness, self-stigma, social anxiety, colorectal cancer, stoma, ostomy, feasibility

Brief summary

Loneliness is a profound health risk for colorectal cancer (CRC) survivors, particularly those with stomas who face significant stigma and social anxiety. According to the hypervigilance model, individuals with loneliness often internalize negative stereotypes and anticipate social rejection, leading to chronic isolation and perceived social isolation. Mindful Self Compassion (MSC) offers a potential solution by targeting the psychological mechanisms of shame and self-criticism. By activating the emotional "soothing system" and fostering a sense of common humanity, self-compassion can buffer the impact of stigma and reduce social fear. Despite its promise, the application of MSC within the oncology-ostomy context has rarely been tested. This randomized controlled pilot trial aims to evaluate the feasibility and preliminary efficacy of an adapted MSC for ostomy patients (MSC-OP) program due to CRC in alleviating loneliness, stigma, and social anxiety through improving self-compassion among CRC patients with ostomy. The findings will determine the suitability of Mindful Self-compassion as a targeted intervention to improve the psychosocial outcomes and social reintegration of this vulnerable population.

Interventions

BEHAVIORALThe MSC-OP group

CRC ostomates will receive MSC-OP in the intervention group delivered by a trained therapist. We will adapt the SC-MSC (six weekly sessions with duration of 1.5 hours for each session) \[41\] for ostomy patients due to CRC. The SC-MSC is a shorted adaptation (9 hours) of the full MSC program created by Dr. Kristin Neff, and her colleague Dr. Christopher Germer. It was designed so that people could learn the key practices needed to transform their relationship with themselves \[41\]. The six sessions are as follows: What is self-compassion? Challenges to practicing self-compassion Discovering your compassionate voice Self-compassion and resilience Self-compassion and others Embracing your life beyond the stoma

BEHAVIORALusual care

CRC ostomates will receive social support, encompassing follow-ups by stoma nurses and social workers. This includes psychoeducation on stoma-related information, self-care, and the navigation of community resources or social-recreational activities. Stoma management support, psychosocial aid, and home-based follow-ups are provided as needed. Emergency stoma-related events are referred to hospital-based specialist nurses.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

A research assistant, blinded to the group allocation, will collect data at baseline and right after the six-week MSC-OP at PolyU campus by questionnaires on loneliness, self-stigma, social anxiety and self-compassion.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age ≥ 18 years old; * colon cancer or rectal cancer patients with stoma; * the stoma won't be reversed within 3 months when conducting the baseline survey; * after surgery of stoma formation; * complete active treatment; * Cantonese or Mandarin speaking.

Exclusion criteria

* Diagnosed with cognitive impairment or dementia (e.g., Alzheimer's disease) as determined using International Classification of Diseases (ICD-10) criteria; * diagnosis of a severe mental disorder; * could not provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Completion rateFrom the start to the end of treatment at 6 weeksThe proportion of total patients who complete the post-intervention evaluations
RetentionFrom the start to the end of treatment at 6 weeksThe proportion of participants who completed the MSC-OP intervention until the end of the study period.
ReachThroughout the recruitment period, approximately 4 monthsThe total number of individuals who respond to the posters via phone or QR code.
Eligibility rateThroughout the recruitment period, approximately 4 monthsThe proportion of responders who meet the inclusion criteria.
Consent rateThroughout the recruitment period, approximately 4 monthsThe proportion of eligible participants who provide signed informed consent;
Recruitment rateThroughout the recruitment period, approximately 4 monthsThe average number of participants enrolled per month
AdherenceFrom the start to the end of treatment at 6 weeksQuantified by the total attendance times at the scheduled 6 sessions of the intervention

Secondary

MeasureTime frameDescription
LonelinessFrom enrollment to the end of treatment at 6 weeksThe 6-item Chinese version of the UCLA Loneliness Scale (ULS-6). Items (e.g., "How often do you feel that you lack companionship?") are rated from 1 ("Never") to 4 ("Often") with a total score from 6 to 24. Higher total scores reflect greater levels of perceived loneliness.
Self-compassionFrom enrollment to the end of treatment at 6 weeksthe 12-item Neff Self-compassion Scale (SCS). Items are rated on a 5-point Likert scale ranging from 1("Almost never") to 5 ("Almost always") with a total score ranges from 12 to 60. A higher score reflects greater levels of self-compassion.
Self-stigmaFrom enrollment to the end of treatment at 6 weeksthe 9-item Self-Stigma Scale-Short (SSS-S) Respondents rate their agreement on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree) with a total score from 9 to 36. Higher score reflecting higher level of self-stigma.
Social anxietyFrom enrollment to the end of treatment at 6 weeksThe Social Phobia Scale (SPS) Responses are recorded on a 5-point Likert-type scale from 0 ("Not at all characteristic or true of me") to 4 ("Extremely characteristic or true of me") with a total score ranging from 0 to 80. A higher score reflects higher social anxiety.

Contacts

CONTACTMinjie Li
minjie.li@polyu.edu.hk852-62143127
CONTACTMan Huen Ng
ng55442858@gmail.com852-55442858

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026